LIVE WEBINAR
Advancing Precision Oncology: Immune-Humanized Mice for Preclinical Drug Evaluation
Learn how Cyagen’s huHSC-NKG-ProF model enhances immune reconstitution to support more predictive immunotherapy studies. Led by immunology expert Dr. Joyce Yu, this session explores model applications in ADCC, tumor vaccines, and immune-targeted combination therapies—along with CRO strategies for translational success.
DATE
09:00 AM – 10:00 AM PDT
LOCATION
Online Webinar | YouTube
Webinar Overview
This webinar introduces huHSC-NKG-ProF, a next-generation immune-humanized mouse model developed to address the limitations of traditional immunodeficient mice in oncology drug research. Featuring improved human immune cell reconstitution, the model offers enhanced predictive value for evaluating the efficacy and safety of cancer therapeutics—particularly for applications such as tumor vaccines, ADCC-based therapies, and immunotherapy combinations.
Led by immunology expert Dr. Joyce Yu, the session will walk through key challenges in translational oncology, practical case applications of huHSC-NKG-ProF, and how Cyagen’s CRO services can support more clinically relevant preclinical studies in immuno-oncology.
Topic Covered
- Limitations of current immunodeficient models in cancer research
- Advantages of the huHSC-NKG-ProF mouse model for immune reconstitution
- Application in ADCC, tumor vaccines, and immunotherapy combinations
- Overview of Cyagen’s CRO support for oncology drug development
Who Should Attend
- Researchers in tumor biology and immuno-oncology
- Professionals involved in cancer drug development and preclinical testing
- Scientists developing tumor vaccines or immune-based therapies
- Ideal for PhD/Master-level researchers in academia, biotech, or pharma
Attend this Webinar to:
- Understand key limitations of traditional mouse models in oncology
- Learn how huHSC-NKG-ProF enhances translational relevance
- Explore real-world applications in immune-targeted drug evaluation
- Discover how Cyagen supports oncology-focused preclinical studies
Webinar Presenter
{{value.name}}
{{value.title}}
{{value.company}}
{{value.descript}}
Discover Our Solutions
Cyagen provides advanced immune-humanized mouse models like huHSC-NKG-ProF to improve the translational accuracy of oncology drug studies. Designed to support immune reconstitution and functional testing, these models are ideal for evaluating immunotherapies, tumor vaccines, and combination strategies. Our oncology-focused CRO services further enable comprehensive in vivo efficacy assessment, immune profiling, and customized study design to accelerate drug development.
{{ value.label }}
{{ value.name }}
Explore
Request Information About This Webinar
Whether you're joining live or catching up later, fill out the form to receive materials or updates related to this webinar.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.